Stine Krag Brunvold 5/16/22 Stine Krag Brunvold 5/16/22

Meet us at Bio€quity 2022

Stine Krag Brunvold 5/10/22 Stine Krag Brunvold 5/10/22

NMD Pharma appoints Dr. Jorge A. Quiroz as EVP, Chief Medical Officer

Stine Krag Brunvold 5/3/22 Stine Krag Brunvold 5/3/22

NMD Pharma expands its US presence

Stine Krag Brunvold 4/28/22 Stine Krag Brunvold 4/28/22

NMD Pharma meets with the Danish Chamber of Commerce

Stine Krag Brunvold 4/20/22 Stine Krag Brunvold 4/20/22

We will be taking part in the ICFSR conference

Stine Krag Brunvold 4/6/22 Stine Krag Brunvold 4/6/22

NMD Pharma will be attending DKBIO

Stine Krag Brunvold 3/21/22 Stine Krag Brunvold 3/21/22

NMD Pharma formår igen at rejse kapital – ser muligheder i bedre offentligt-privat samarbejde

Stine Krag Brunvold 3/15/22 Stine Krag Brunvold 3/15/22

Sachs 5th Annual Neuroscience Innovation Forum

Stine Krag Brunvold 3/3/22 Stine Krag Brunvold 3/3/22

Welcome to David Evans

Stine Krag Brunvold 2/24/22 Stine Krag Brunvold 2/24/22

Welcome to Sabine Dandiguian

Stine Krag Brunvold 2/15/22 Stine Krag Brunvold 2/15/22

NMD Pharma Raises €35 Million in a new Financing

Stine Krag Brunvold 12/16/21 Stine Krag Brunvold 12/16/21

Join us virtually for BIO Partnering at JPM January 10-14, 2022

Stine Krag Brunvold 7/8/21 Stine Krag Brunvold 7/8/21

NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease

Stine Krag Brunvold 6/30/21 Stine Krag Brunvold 6/30/21

NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670

Stine Krag Brunvold 6/25/21 Stine Krag Brunvold 6/25/21

Interview with Professor, Dr. Geert Jan Groeneveld about myasthenia gravis

Stine Krag Brunvold 6/1/21 Stine Krag Brunvold 6/1/21

NMD Pharma Initiates an Observational Pilot Study Investigating the Effects of Sarcopenia on Neuromuscular Transmission in Older Adults

Stine Krag Brunvold 5/28/21 Stine Krag Brunvold 5/28/21

Muscular chloride channel inhibition improves neuromuscular function

Stine Krag Brunvold 4/29/21 Stine Krag Brunvold 4/29/21

Sachs 4th Annual Neuroscience Innovation Forum

Stine Krag Brunvold 2/17/21 Stine Krag Brunvold 2/17/21

The first Oligonucleotides for CNS

It all begins with an idea.

Stine Krag Brunvold 1/26/21 Stine Krag Brunvold 1/26/21

Aarhus Biotech Company takes up the fight against neuromuscular diseases

It all begins with an idea.